Exploring NFκB pathway as a potent strategy to mitigate COVID-19 severe morbidity and mortality

The pandemic of coronavirus disease 2019 (COVID-19), for which there does not appear to be an approved cure, the primary treatment options consist of non-pharmacological preventive measures and supportive treatment that are aimed at halting the progression of the disease. Nuclear factor kappa B (NFk...

Descripción completa

Detalles Bibliográficos
Autores principales: Muhammad, Mubarak, Hassan, Tasneem M., Baba, Sani S., Radda, Mustapha I., Mutawakkil, Mubarak M., Musa, Majida A., AbuBakar, Sazaly, Loong, Shih Keng, Yusuf, Ibrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614690/
https://www.ncbi.nlm.nih.gov/pubmed/36313924
http://dx.doi.org/10.4081/jphia.2022.1679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614690/
https://www.ncbi.nlm.nih.gov/pubmed/36313924
http://dx.doi.org/10.4081/jphia.2022.1679

Ejemplares similares